In this third edition e-book, we look at some of the successful discovery and development methods for next-generation monoclonal antibody-based therapeutics and vaccines. These methods incorporate innovative, high-throughput, and automated solutions such as the iQue®, Incucyte®, and Octet® advanced cell and protein analysis platforms from Sartorius. These leading technologies are designed to enable rapid identification and characterization of candidate molecules with superior target reactivity and optimized functionality. Read Now.
FibroBiologics CEO and founder Pete O'Heeron shares the journey that led him from clinical care to biopharma entrepreneurship, and he's joined by chief scientific officer Hamid Khoja, Ph.D., who explains the manufacturing technology that's driving the company's exploitation of fibroblasts to develop regenerative therapies for indications ranging from degenerative disk disease and multiple sclerosis to cancer immunotherapies and therapeutics. Listen now to the Business of Biotech podcast and subscribe so you never miss an episode.